InterShunt
St Louis
About InterShunt
InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe they can do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Jun 2023)
- Website: intershunt.com
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/intershunt-30927 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.